CVE-2025-36020

IBM Guardium Data Protection information disclosure

Description

IBM Guardium Data Protection could allow a remote attacker to obtain sensitive information due to cleartext transmission of sensitive credential information.

Remediation

Solution:

  • IBM encourages customers to update their systems promptly. Product Versions   Fix IBM Guardium Data Protection 11.5 https://www.ibm.com/support/fixcentral/swg/quickorder?parent=IBM%20Security&product=ibm/Informat... https://www.ibm.com/support/fixcentral/swg/quickorder

Category

5.9
CVSS
Severity: Medium
CVSS 3.1 •
EPSS 0.02%
Vendor Advisory ibm.com
Affected: IBM Guardium Data Protection
Published at:
Updated at:

References

Link Tags
https://www.ibm.com/support/pages/node/7241547 patch vendor advisory

Frequently Asked Questions

What is the severity of CVE-2025-36020?
CVE-2025-36020 has been scored as a medium severity vulnerability.
How to fix CVE-2025-36020?
To fix CVE-2025-36020: IBM encourages customers to update their systems promptly. Product Versions   Fix IBM Guardium Data Protection 11.5 https://www.ibm.com/support/fixcentral/swg/quickorder?parent=IBM%20Security&product=ibm/Informat... https://www.ibm.com/support/fixcentral/swg/quickorder
Is CVE-2025-36020 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2025-36020 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2025-36020?
CVE-2025-36020 affects IBM Guardium Data Protection.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.